Last 12 months
Inside the activity.
4 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2022 Filed Oct 11, 2022 20:10 UTC |
Faber AlexisChief Operating Officer
|
GrantRestricted Share Unit · Derivative | 14.088 | $204.93 | $2,887.05 |
DisclosureSEC source: 0001127602-22-023853 · form4.xml · derivative · entry 3 Faber Alexis · CIK 0001882149 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713.946 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 14.088 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:10 UTC |
Faber AlexisChief Operating Officer
|
GrantRestricted Share Unit · Derivative | 24.6537 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023853 · form4.xml · derivative · entry 2 Faber Alexis · CIK 0001882149 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,467.9527 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 24.6537 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:10 UTC |
Faber AlexisChief Operating Officer
|
GrantRestricted Share Unit · Derivative | 42.2637 | $204.93 | $8,661.10 |
DisclosureSEC source: 0001127602-22-023853 · form4.xml · derivative · entry 1 Faber Alexis · CIK 0001882149 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443.299 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.2637 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:08 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
GrantRestricted Share Unit · Derivative | 27.8697 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023852 · form4.xml · derivative · entry 2 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,038.7991 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 27.8697 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:08 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
GrantRestricted Share Unit · Derivative | 47.7764 | $204.93 | $9,790.82 |
DisclosureSEC source: 0001127602-22-023852 · form4.xml · derivative · entry 1 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,010.9294 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 47.7764 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:07 UTC |
Qureshi Imran AhmedHead of North America
|
GrantRestricted Share Unit · Derivative | 23.5818 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023851 · form4.xml · derivative · entry 2 Qureshi Imran Ahmed · CIK 0001881795 · Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989.7319 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.5818 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:07 UTC |
Qureshi Imran AhmedHead of North America
|
GrantRestricted Share Unit · Derivative | 40.4261 | $204.93 | $8,284.52 |
DisclosureSEC source: 0001127602-22-023851 · form4.xml · derivative · entry 1 Qureshi Imran Ahmed · CIK 0001881795 · Head of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,966.1501 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 40.4261 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:06 UTC |
Pullum AnneHead of Europe
|
GrantRestricted Share Unit · Derivative | 15.3129 | $204.93 | $3,138.07 |
DisclosureSEC source: 0001127602-22-023850 · form4.xml · derivative · entry 3 Pullum Anne · CIK 0001688834 · Head of Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634.1546 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 15.3129 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:06 UTC |
Pullum AnneHead of Europe
|
GrantRestricted Share Unit · Derivative | 32.3947 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023850 · form4.xml · derivative · entry 2 Pullum Anne · CIK 0001688834 · Head of Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,382.3421 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 32.3947 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:06 UTC |
Pullum AnneHead of Europe
|
GrantRestricted Share Unit · Derivative | 55.5337 | $204.93 | $11,380.52 |
DisclosureSEC source: 0001127602-22-023850 · form4.xml · derivative · entry 1 Pullum Anne · CIK 0001688834 · Head of Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349.9474 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 55.5337 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:05 UTC |
Kurpis Joseph StephenPAO and Controller
|
GrantRestricted Share Unit · Derivative | 13.8658 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023849 · form4.xml · derivative · entry 2 Kurpis Joseph Stephen · CIK 0001497048 · PAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164.5404 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13.8658 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:05 UTC |
Kurpis Joseph StephenPAO and Controller
|
GrantRestricted Share Unit · Derivative | 23.7698 | $204.93 | $4,871.15 |
DisclosureSEC source: 0001127602-22-023849 · form4.xml · derivative · entry 1 Kurpis Joseph Stephen · CIK 0001497048 · PAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150.6746 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.7698 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
GrantRestricted Share Unit · Derivative | 19.6006 | $204.93 | $4,016.75 |
DisclosureSEC source: 0001127602-22-023848 · form4.xml · derivative · entry 3 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90.8711 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 19.6006 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
GrantRestricted Share Unit · Derivative | 34.3009 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023848 · form4.xml · derivative · entry 2 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212.4471 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 34.3009 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
GrantRestricted Share Unit · Derivative | 58.8014 | $204.93 | $12,050.17 |
DisclosureSEC source: 0001127602-22-023848 · form4.xml · derivative · entry 1 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178.1462 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 58.8014 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:03 UTC |
Hess Carl AaronDirector · Chief Executive Officer
|
GrantRestricted Share Unit · Derivative | 42.8767 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023846 · form4.xml · derivative · entry 2 Hess Carl Aaron · CIK 0001435988 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,138.8021 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.8767 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:03 UTC |
Hess Carl AaronDirector · Chief Executive Officer
|
GrantRestricted Share Unit · Derivative | 73.5031 | $204.93 | $15,062.99 |
DisclosureSEC source: 0001127602-22-023846 · form4.xml · derivative · entry 1 Hess Carl Aaron · CIK 0001435988 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,095.9254 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 73.5031 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:02 UTC |
Gebauer Julie JareckeHead of Health, Wealth &Career
|
GrantRestricted Share Unit · Derivative | 27.8697 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023845 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,590.18 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 27.8697 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:02 UTC |
Gebauer Julie JareckeHead of Health, Wealth &Career
|
GrantRestricted Share Unit · Derivative | 47.7765 | $204.93 | $9,790.84 |
DisclosureSEC source: 0001127602-22-023845 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,562.3103 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 47.7765 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:02 UTC |
Furman MatthewGeneral Counsel
|
GrantRestricted Share Unit · Derivative | 14.4556 | $204.93 | $2,962.39 |
DisclosureSEC source: 0001127602-22-023844 · form4.xml · derivative · entry 3 Furman Matthew · CIK 0001637389 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,910.8358 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 14.4556 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:02 UTC |
Furman MatthewGeneral Counsel
|
GrantRestricted Share Unit · Derivative | 25.2972 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023844 · form4.xml · derivative · entry 2 Furman Matthew · CIK 0001637389 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,008.0403 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 25.2972 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:02 UTC |
Furman MatthewGeneral Counsel
|
GrantRestricted Share Unit · Derivative | 43.3665 | $204.93 | $8,887.10 |
DisclosureSEC source: 0001127602-22-023844 · form4.xml · derivative · entry 1 Furman Matthew · CIK 0001637389 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982.7431 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 43.3665 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:01 UTC |
Bodnar Anne DonovanChief Administrative Officer
|
GrantRestricted Share Unit · Derivative | 23.5819 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023843 · form4.xml · derivative · entry 2 Bodnar Anne Donovan · CIK 0001629374 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,897.2371 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.5819 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:01 UTC |
Bodnar Anne DonovanChief Administrative Officer
|
GrantRestricted Share Unit · Derivative | 40.4261 | $204.93 | $8,284.52 |
DisclosureSEC source: 0001127602-22-023843 · form4.xml · derivative · entry 1 Bodnar Anne Donovan · CIK 0001629374 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,873.6552 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 40.4261 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for US Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:00 UTC |
Banas Kristy DChief Human Resources Officer
|
GrantRestricted Share Unit · Derivative | 10.7804 | $204.93 | $2,209.23 |
DisclosureSEC source: 0001127602-22-023842 · form4.xml · derivative · entry 3 Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262.6375 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10.7804 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. F4 · derivative.exercise_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:00 UTC |
Banas Kristy DChief Human Resources Officer
|
GrantRestricted Share Unit · Derivative | 18.8655 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023842 · form4.xml · derivative · entry 2 Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461.6515 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 18.8655 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 20:00 UTC |
Banas Kristy DChief Human Resources Officer
|
GrantRestricted Share Unit · Derivative | 32.3408 | $204.93 | $6,627.60 |
DisclosureSEC source: 0001127602-22-023842 · form4.xml · derivative · entry 1 Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442.786 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 32.3408 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 21:00 UTC |
Gebauer Julie JareckeHead of Health, Wealth &Career
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $210.00 | $294,000.00 |
DisclosureSEC source: 0001127602-22-023723 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,755 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:02 UTC |
REILLY PAUL CDirector
|
GrantOrdinary Shares, nominal value $0.000304635 per share | 746 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023535 · form4.xml · nonDerivative · entry 1 REILLY PAUL C · CIK 0001240439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746 F1 · shares: Comprised of 746 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of the date of the Issuer's 2023 Annual General Meeting of Shareholders and October 1, 2023. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
OtherDividend Equivalent Rights · Derivative | 64 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022240 · form4.xml · derivative · entry 4 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135.223 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 64 shares Expires not disclosed F5 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F5 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F5 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's time-based restricted share unit award and were credited in the form of additional restricted share units that vested and were payable at the same time as the underlying time-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 1,030 | $210.26 | $216,569.96 |
DisclosureSEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 3 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 2,178 F3 · price: This transaction was executed in multiple trades at prices ranging from $210.21 to $210.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Reflects a transfer of 2,709 shares to the reporting person's revocable trust following the vesting and settlement reported above. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 1,758 | $204.92 | $360,249.36 |
DisclosureSEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 2 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,200 F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 4,467 restricted share units granted on September 7, 2021. F2 · balance_after: Does not reflect a transfer of 2,709 shares to the reporting person's revocable trust following the vesting and settlement reported above. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:04 UTC |
Krasner Andrew JayChief Financial Officer
|
OtherOrdinary Shares, nominal value $0.000304635 per share | 64 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022240 · form4.xml · nonDerivative · entry 1 Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,958 Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,925 | $0.00 Strike: $110.58 | $0.00 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · derivative · entry 8 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13,925 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 1,975 | $209.86 | $414,473.50 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 6 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,474.836 F5 · price: This transaction was executed in multiple trades at prices ranging from $209.40 to $210.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 1,712 | $208.65 | $357,208.80 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 5 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,449.836 F4 · price: This transaction was executed in multiple trades at prices ranging from $208.35 to $209.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 4,132 | $207.52 | $857,472.64 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 4 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,161.836 F3 · price: This transaction was executed in multiple trades at prices ranging from $207.32 to $207.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 3,477 | $206.61 | $718,382.97 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 3 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,293.836 F2 · price: This transaction was executed in multiple trades at prices ranging from $206.25 to $207.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 2,629 | $205.88 | $541,258.52 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 2 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,770.836 F1 · price: This transaction was executed in multiple trades at prices ranging from $205.25 to $206.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:02 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share | 13,925 | $110.58 | $1,539,826.50 |
DisclosureSEC source: 0001127602-22-022238 · form4.xml · nonDerivative · entry 1 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,399.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:00 UTC |
Gebauer Julie JareckeHead of Health, Wealth &Career
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $210.00 | $294,002.94 |
DisclosureSEC source: 0001127602-22-022093 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,155 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. F2 · price: This transaction was executed in multiple trades at prices ranging from $210.00 to $210.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $110.58 | $0.00 |
DisclosureSEC source: 0001127602-22-021760 · form4.xml · derivative · entry 4 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,925 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10,000 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 10,000 | $209.47 | $2,094,700.00 |
DisclosureSEC source: 0001127602-22-021760 · form4.xml · nonDerivative · entry 2 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,474.836 Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share | 10,000 | $110.58 | $1,105,800.00 |
DisclosureSEC source: 0001127602-22-021760 · form4.xml · nonDerivative · entry 1 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,474.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,487 | $0.00 Strike: $110.58 | $0.00 |
DisclosureSEC source: 0001127602-22-021427 · form4.xml · derivative · entry 4 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,925 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 22,487 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 22,487 | $220.00 | $4,947,140.00 |
DisclosureSEC source: 0001127602-22-021427 · form4.xml · nonDerivative · entry 2 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,474.836 Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share | 22,487 | $110.58 | $2,486,612.46 |
DisclosureSEC source: 0001127602-22-021427 · form4.xml · nonDerivative · entry 1 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,961.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionStock Option (right to buy) · Derivative | 398 | $0.00 Strike: $110.58 | $0.00 |
DisclosureSEC source: 0001127602-22-021301 · form4.xml · derivative · entry 7 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,412 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 398 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
SaleOrdinary Shares, nominal value $0.000304635 per share | 398 | $220.00 | $87,560.00 |
DisclosureSEC source: 0001127602-22-021301 · form4.xml · nonDerivative · entry 4 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,474.836 Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:00 UTC |
WICKES GENE HHead of Benefits Deliv & Admin
|
Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share | 398 | $110.58 | $44,010.84 |
DisclosureSEC source: 0001127602-22-021301 · form4.xml · nonDerivative · entry 3 WICKES GENE H · CIK 0001213376 · Head of Benefits Deliv & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,872.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.